Sign in

CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
520845822
Phone
352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Open-market buy CEO & President bought 39,000 shares at $0.14 ($5,382)
  2. 4 Open-market buy CEO & President bought 31,298 shares at $0.16 ($5,070)
  3. 4 Open-market buy CEO & President bought 12,751 shares at $0.16 ($2,015)
  4. 4 Open-market buy CEO & President bought 20,299 shares at $0.16 ($3,167)
  5. 4 Open-market buy CEO & President bought 31,675 shares at $0.16 ($5,068)
  6. 4 Open-market buy CEO & President bought 31,250 shares at $0.16 ($5,094)
  7. 4 Open-market buy CEO & President bought 24,000 shares at $0.21 ($4,992)
  8. 4 Open-market buy CEO & President bought 11,000 shares at $0.21 ($2,310)
  9. 4 Open-market buy CEO & President bought 22,000 shares at $0.22 ($4,862)
  10. 4 Open-market buy CEO & President bought 5,900 shares at $0.22 ($1,292)
  11. 4 Conversion CEO & President acquired 25,000 shares (conversion)
  12. 4 Conversion Director acquired 25,000 shares (conversion)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 2,800 shares (grant or award)
  16. 4 Insider Changes in Ownership
  17. 4 Open-market buy CEO & President bought 107 shares at $7.70 ($824)
  18. 4 Open-market buy CEO & President bought 103 shares at $8.70 ($896)
  19. 4 Open-market buy Director bought 196,851 shares at $0.03 ($5,000)
  20. 4 Open-market buy CEO & President bought 1,968,504 shares at $0.03 ($50,000)

Page 1 of 31 · 613 filings